David Hedley
8Patents
2h-index
16Co-inventors
44Inventor score
Filing activity: Aug 27, 2004 → Sep 18, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9642856B2 | Treatment for pancreatic cancer | Chemistry; Metallurgy | 5 | Active |
| US10222380B2 | Organotellurium compounds, compositions and methods of use thereof | Emerging Cross-Sectional Technologies | 2 | Active |
| US7803523B2 | Whole blood preparation for cytometric analysis of cell signaling pathways | Emerging Cross-Sectional Technologies | 2 | Active |
| US10816552B2 | Organotellurium compounds, compositions and methods of use thereof | Emerging Cross-Sectional Technologies | 1 | Active |
| US10073082B2 | Proteasome inhibition assay and methods of use | Physics | 0 | Active |
| US9040249B2 | Pan-kinase activation and evaluation of signaling pathways | Physics | 0 | Active |
| US9555042B2 | Treatment for pancreatic cancer | General | 0 | Revoked |
| US12135325B2 | Organotellurium compounds, compositions and methods of use thereof | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.